|drug1799||LSALT peptide Wiki||1.00|
|drug61||A vignette intervention Wiki||1.00|
|D058186||Acute Kidney Injury NIH||0.22|
|D014947||Wounds and Injuries NIH||0.19|
There is one clinical trial.
Coronavirus disease 2019 (COVID-19) has widely and rapidly spread around the world, overwhelming intensive care units and health care capacity. While the physical risk (e.g. pneumonia, respiratory breakdown) is getting the most scientific and clinical attention, this outbreak also has significant mental health risks and extreme psychological fear-related responses. Among the general population, there are high-risk groups as elderly people, disabled individuals and people with previous exposure to trauma (e.g., people with military experience). Veterans are among the subgroups who are high risk for PTSD and other mental health problem. The overarching goal of this study is to examine the efficacy of an online, largescale, brief video-based intervention in reducing fear and stress and improving help seeking behavior in relate to COVID-19.
Description: 5 questions that test help seeking attitudesMeasure: Help seeking behavior Time: one minute
Description: Generalized Anxiety ScreenMeasure: GAD-7 Time: 2 minutes
Description: Major Depression screenMeasure: PHQ-9 Time: 2 minutes
Description: Brief PTSD screenMeasure: PC-PTSD Time: 1 minute
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports